[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 05.12(금)

Global Data Intelligence Center
구분	보고서 (영문)	업로드 날짜
제약/바이오/ 임상시험	Merck Bets Big on PRA023 and Inflammatory Bowel Diseases With $10.8B Prometheus Acquisition Offer	04-28-2023
	NICE Recommends First Treatment for Incurable Cervical Cancer in 14 Years	04-27-2023
	CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia	04-27-2023
	AZ to Terminate Once-Daily Cotadutide Program to Focus on Weekly GLP-1RA Co-Agonist	04-25-2023
	As Cytokinetics’s ALS Drug Fails Phase III Trial, Attention Turns to Cardiomyopathy Candidate	04-24-2023
	FDA Has Pushed Back on Approving Mirikizumab Due to Manufacturing Issues	04-20-2023
	OncoSec’s Tavo Reaches Tipping Point with Latest Phase IIb Results	04-20-2023
	Moderna Announces Development of New Treatments for Lyme Disease	04-20-2023
	Bristol Myers Squibb’s Blockbuster Sotyktu Scores European Nod for Plaque Psoriasis	04-20-2023
질환별	Melanoma: Cell & Gene Therapies 15-Market Assessment and Forecast	04-28-2023
	Body Dysmorphic Disorder: Competitive Landscape	04-27-2023
	Allergic Conjunctivitis: Competitive Landscape	04-21-2023
	Idiopathic Pulmonary Fibrosis: Competitive Landscape	04-20-2023
컨퍼런스/ 심포지엄/ 학회 등	AAN 2023: Importance of Education for Levodopa Infusions in Parkinson’s	04-26-2023
	AAN 2023: AbbVie Highlights Qulipta’s Edge over Oral Migraine Prophylaxis	04-26-2023
	AAN 2023: Amneal’s IPX203 Shows Promise for Parkinson’s Disease Patients	04-26-2023
	Highlights from AACR 2023: KRAS Inhibitor Pipeline Candidates Gain Momentum	04-26-2023
	AACR 2023: TRAVERSE - First-in-Human Trial of Allogeneic Anti-CD70 CAR-T Candidate Shows Promise for Advanced Renal Cell Carcinoma	04-24-2023
	ECCMID 2023: Highlights on findings for viral, bacterial, and fungal infections in 2022	04-21-2023
	ECCMID 2023: Updating the Global Bacterial Priority Pathogens List	04-21-2023